Bokus

Breaking Tolerance to Antibody-Mediated Immunotherapy – serie

Visar alla böcker i serien Breaking Tolerance to Antibody-Mediated Immunotherapy. Handla med fri frakt och snabb leverans.

4 produkter

  1. New Combination Approaches to Enhance Rituximab-Based Lymphoma Therapies, Inbunden. Tillgänglighet: Kommande

    New Combination Approaches to Enhance Rituximab-Based Lymphoma Therapies

    Inbunden, 2024

    1527 kr

    Kommande

  2. Benjamin Bonavida - Overcoming Cancers Resistant to HER-2 Antibodies, Inbunden. Tillgänglighet: Lägg i varukorg

    Overcoming Cancers Resistant to HER-2 Antibodies

    Av Benjamin Bonavida

    Inbunden, 2024

    1527 kr

    Lägg i varukorg

    Overcoming Cancers Resistant to HER-2 Antibodies provides general updated information on the resistance of various human cancers to anti-HER2 therapeutic antibodies. The book also discusses the description of various sensitizing agents that can reverse resistance when used in combination with …

  3. Shi Hu - Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies, Inbunden. Tillgänglighet: Lägg i varukorg

    Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies

    Av Shi Hu

    Inbunden, 2022

    1818 kr

    Lägg i varukorg

    Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies presents a description of the sensitizers used to overcome resistance to anti-EGFR targeted antibody therapies in cancer, including novel engineered antibody drugs and other sensitizers. The book gives insights into the landscape of …

  4. Resistance to Anti-CD20 Antibodies and Approaches for Their Reversal, Inbunden. Tillgänglighet: Lägg i varukorg

    Resistance to Anti-CD20 Antibodies and Approaches for Their Reversal

    Inbunden, 2023

    1884 kr

    Lägg i varukorg

    Resistance to Anti-CD20 Antibodies and Approaches for Their Reversal presents in-depth content written by international experts in the study of resistance to anti-CD20 antibodies and approaches for their reversal. Anti-CD20 antibodies are used to achieve B cell depletion and are developed to treat …